- Home
- ACA vs CNTA Comparison
ACA vs CNTA Comparison
Compare ACA & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACA | CNTA |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.1B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACA | CNTA |
|---|---|---|
| Price | $125.26 | $39.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $120.00 | $43.17 |
| AVG Volume (30 Days) | 224.7K | ★ 2.4M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 121.99 | 29.13 |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $2,883,400,000.00 | $15,000,000.00 |
| Revenue This Year | $5.26 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | $29.23 | ★ N/A |
| Revenue Growth | ★ 12.20 | N/A |
| 52 Week Low | $81.59 | $10.95 |
| 52 Week High | $131.00 | $40.26 |
Technical Indicators
Market Signals| Indicator | ACA | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 65.67 | 74.15 |
| Support Level | $99.46 | $39.16 |
| Resistance Level | $130.58 | $40.26 |
| Average True Range (ATR) | 4.15 | 0.17 |
| MACD | 1.02 | -0.46 |
| Stochastic Oscillator | 78.90 | 76.47 |
Price Performance
Historical ComparisonAbout ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.